Ptc Therapeutics (PTCT) Work In Process (2019 - 2026)

Ptc Therapeutics' Work In Process history runs 8 years deep, the most recent figure standing at $57.8 million for Q2 2026.

• In Q2 2026, Work In Process rose 137.12% year-over-year to $57.8 million; the TTM figure through Jun 2026 stood at $57.8 million (up 137.12% YoY), while the FY2025 annual figure was $55.7 million, up 355.84% from the prior year.
• Work In Process for Q2 2026 stood at $57.8 million, up from $52.8 million in the prior quarter.
• The five-year high for Work In Process was $57.8 million in Q2 2026, with the low at $7.0 million in Q2 2022.
• The 5-year median for Work In Process is $21.5 million (2023), against an average of $24.8 million.
• Peak annual rise in Work In Process reached 355.84% in 2025, while the deepest fall reached 41.09% in 2025.
• Ptc Therapeutics' Work In Process stood at $14.1 million in 2022, then rose by 27.83% to $18.0 million in 2023, then tumbled by 32.1% to $12.2 million in 2024, then soared by 355.84% to $55.7 million in 2025, then rose by 3.75% to $57.8 million in 2026.
• Business Quant data shows PTCT's Work In Process at $57.8 million in Q2 2026, $52.8 million in Q1 2026, and $55.7 million in Q4 2025.